can-fite biopharma: developing treatments for liver cancer
Published 3 months ago • 405K plays • Length 0:31Download video MP4
Download video MP3
Similar videos
-
6:35
can-fite: addressing autoimmune-inflammatory and cancer diseases
-
8:16
exploring can-fite biopharma's groundbreaking drugs: piclidenoson and namodenoson
-
2:19
can-fite: a remarkable opportunity for investors
-
0:59
how is chemoembolization planned for patients with liver cancer? #shorts
-
1:46
can-fite's phase ii liver cancer trial approved in europe
-
9:19
can-fite biopharma ltd. (nyse american: canf) (tase: canf)
-
0:48
complex care: liver cancer treatments
-
1:17
dr. cohen on eligibility for ablation therapy in liver cancer
-
26:57
redchip tv highlights os therapies (nyse american: ostx) & can-fite biopharma (nyse american: canf)
-
2:18
can-fite's cf102 approved for compassionate use in israel for liver cancer patient
-
5:01
late-stage trials targeting multiple indications: exclusive interview with can-fite’s ceo
-
4:56
liver cancer - causes, signs & symptoms, diagnosis, treatment | dr tan hon lyn (medical oncologist)
-
2:12
can-fite issued japanese patent for treatment of liver regeneration
-
0:23
#cicon24 | day 3 | dr. marina baretti
-
0:16
best liver cancer treatment
-
1:51
can-fite announces pre-clinical data on cf102 in the treatment of nash
-
1:42
embolization therapy for liver cancer
-
0:37
ask dr. keith unger: can proton therapy treat liver tumors?
-
1:44
can-fite announces upcoming 2015 clinical milestones for its pipeline of drugs in 4 indications